Adenovirus-based overexpression of tissue inhibitor of metalloproteinases 1 reduces tissue damage in the joints of tumor necrosis factor alpha transgenic mice (Q64379379)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 December 2001

Language	Label	Description	Also known as
English	Adenovirus-based overexpression of tissue inhibitor of metalloproteinases 1 reduces tissue damage in the joints of tumor necrosis factor alpha transgenic mice	scientific article published on 01 December 2001

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Adenovirus-based overexpression of tissue inhibitor of metalloproteinases 1 reduces tissue damage in the joints of tumor necrosis factor alpha transgenic mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

based on heuristic

inferred from title

Giorgos Kollias

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

G Schett

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

S Hayer

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

M Tohidast-Akrad

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

B J Schmid

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

S Lang

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

B Türk

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

F Kainberger

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

S Haralambous

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

A C Newby

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Q Xu

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

G Steiner

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

J Smolen

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

language of work or name

0 references

publication date

1 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Arthritis and Rheumatism

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

44

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

2888-2898

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Role of cytokines in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

The mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Cloning of the gene for interstitial collagenase-3 (matrix metalloproteinase-13) from rabbit synovial fibroblasts: differential expression with collagenase-1 (matrix metalloproteinase-1).

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

TNF-alpha-mediated expression of membrane-type matrix metalloproteinase in rheumatoid synovial fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Rheumatoid arthritis synovial macrophage-osteoclast differentiation is osteoprotegerin ligand-dependent

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Bone resorption by osteoclasts

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis: a parallel investigation by semiquantitative reverse transcriptase-polymerase chain rea

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Levels of rheumatoid factor isotypes, metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in synovial fluid from various arthritides

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti- tumour necrosis factor-alpha (cA2) therapy

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in rheumatoid synovium

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Cleavage of aggrecan at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Collagenase, cathepsin B and cathepsin L gene expression in the synovial membrane of patients with early inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Insights into MMP-TIMP interactions.

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Matrix metalloproteinases, but not cathepsins B, H, and L or their inhibitors in peripheral blood of patients with rheumatoid arthritis are potentially useful markers of disease activity

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis.

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Rheumatoid synovial endothelial cells secrete decreased levels of tissue inhibitor of MMP (TIMP1).

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Suppression of adjuvant arthritis of rats by a novel matrix metalloproteinase-inhibitor

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Thirty-six years in the clinic without an MMP inhibitor. What hath collagenase wrought?

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Using inhibitors of metalloproteinases to treat arthritis. Easier said than done?

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Hand radiography of 200 patients with rheumatoid arthritis repeated after an interval of one year

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

B and T cell responses to the spliceosomal heterogeneous nuclear ribonucleoproteins A2 and B1 in normal and lupus mice

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF alpha processing in RA synovial membrane cell cultures

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Pannus and pannocytes. Alternative models of joint destruction in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Identifiers

10.1002/1529-0131(200112)44:12<2888::AID-ART477>3.0.CO;2-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64379379&oldid=2128323312"